-
Open Access Journal of Clinical Trials
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Conducting ethical clinical trials for L. donovani in the Bihar region of India
Perspectives
(1899) Views (513) Full article downloads
Authors: Tiffany Crawford, Brian Vesely
Published Date August 2010
Volume 2010:2 Pages 125 - 131
DOI: http://dx.doi.org/10.2147/OAJCT.S10967
Tiffany Crawford, Brian VeselyGlobal Health, University of South Florida, Tampa, FL, USA
Abstract: Visceral leishmaniasis is a severe disease that disproportionally afflicts the Bihar state in India with 40% of the worldwide disease burden. Drug resistance, poor adherence, extreme poverty, malnutrition and certain living conditions have made control and treatment of the disease difficult. There is a great need for new drugs and control programs to reduce the disease burden of this debilitating and potentially fatal disease. Drug discovery research on leishmaniasis is being conducted in the USA and this raises issues concerning the ethical conduct of international clinical trials. Ethical principles dictate that the Bihari who need these drugs should be included in clinical trials. Additional safeguards for the ethical conduct of clinical trials on developing countries by developed countries have been formulated elsewhere. These include collaborative partnership, social value, scientific validity, fair selection of study population, favorable risk-benefit ratio, independent review, informed consent, and respect for recruited participants and study communities. These principles are applied to the Bihari context, and issues of ancillary care and post-trial access are also addressed. The socio-cultural context of the region is discussed in order to give researchers the tools to obtain meaningful informed consent. A description of the Bihari context and relevant ethical considerations should facilitate the design and conduct of ethical clinical trials for L. donovani.
Keywords: L. donovani, ethics, clinical trials, Bihar
Readers of this article also read:
Research methodological issues in evaluating herbal interventions
Pharmacological modeling and biostatistical analysis of a new drug
The role of print advertising in clinical trial recruitment: Lessons from a South African site
Clinical data management: Current status, challenges, and future directions from industry perspectives
Time will tell: community acceptability of HIV vaccine research before and after the “Step Study” vaccine discontinuation
Examining the readability of patient-informed consent forms
Examining the clinical trial feasibility process and its implications for a trial site
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Helicobacter pylori infection and primary open-angle glaucoma: is there a connection?
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- The benefits and risks of testosterone replacement therapy: a review
- Tenofovir-associated bone density loss
- Drug design with Cdc7 kinase: a potential novel cancer therapy target
- Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses




